High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

TG Steenbruggen; LC Steggink; Caroline Seynaeve; JJ van der Hoeven; Maartje Hooning; Agnes Jager; IR Konings; J R Kroep; WM Smit; VC Tjan-Heijnen; E van der Wall; AD Bins; SC Linn; M Schaapveld; JN Jacobse; FE van Leeuwen; CP Schroder; H van Tinteren; E Vries; GS Sonke; JA Gietema

doi:10.1001/jamaoncol.2019.6276

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

TG Steenbruggen, LC Steggink, Caroline Seynaeve, JJ van der Hoeven, Maartje Hooning, Agnes Jager, IR Konings, J R Kroep, WM Smit, VC Tjan-Heijnen, E van der Wall, AD Bins, SC Linn, M Schaapveld, JN Jacobse, FE van Leeuwen, CP Schroder, H van Tinteren, E Vries, GS SonkeJA Gietema

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	528-534
Number of pages	7
Journal	JAMA Oncology
Volume	6
Issue number	4
Early online date	30 Jan 2020
DOIs	https://doi.org/10.1001/jamaoncol.2019.6276
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2019.6276

Cite this

Steenbruggen, TG., Steggink, LC., Seynaeve, C., van der Hoeven, JJ., Hooning, M., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, VC., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., Jacobse, JN., van Leeuwen, FE., Schroder, CP., van Tinteren, H., Vries, E., ... Gietema, JA. (2020). High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. JAMA Oncology, 6(4), 528-534. Advance online publication. https://doi.org/10.1001/jamaoncol.2019.6276

@article{0cc97eb6640843a0b783f6e21418b073,

title = "High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial",

author = "TG Steenbruggen and LC Steggink and Caroline Seynaeve and {van der Hoeven}, JJ and Maartje Hooning and Agnes Jager and IR Konings and Kroep, {J R} and WM Smit and VC Tjan-Heijnen and {van der Wall}, E and AD Bins and SC Linn and M Schaapveld and JN Jacobse and {van Leeuwen}, FE and CP Schroder and {van Tinteren}, H and E Vries and GS Sonke and JA Gietema",

year = "2020",

doi = "10.1001/jamaoncol.2019.6276",

language = "English",

volume = "6",

pages = "528--534",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "4",

}

Steenbruggen, TG, Steggink, LC, Seynaeve, C, van der Hoeven, JJ, Hooning, M , Jager, A, Konings, IR, Kroep, JR, Smit, WM, Tjan-Heijnen, VC, van der Wall, E, Bins, AD, Linn, SC, Schaapveld, M, Jacobse, JN, van Leeuwen, FE, Schroder, CP, van Tinteren, H, Vries, E, Sonke, GS & Gietema, JA 2020, 'High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial', JAMA Oncology, vol. 6, no. 4, pp. 528-534. https://doi.org/10.1001/jamaoncol.2019.6276

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. / Steenbruggen, TG; Steggink, LC; Seynaeve, Caroline et al.
In: JAMA Oncology, Vol. 6, No. 4, 2020, p. 528-534.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

AU - Steenbruggen, TG

AU - Steggink, LC

AU - Seynaeve, Caroline

AU - van der Hoeven, JJ

AU - Hooning, Maartje

AU - Jager, Agnes

AU - Konings, IR

AU - Kroep, J R

AU - Smit, WM

AU - Tjan-Heijnen, VC

AU - van der Wall, E

AU - Bins, AD

AU - Linn, SC

AU - Schaapveld, M

AU - Jacobse, JN

AU - van Leeuwen, FE

AU - Schroder, CP

AU - van Tinteren, H

AU - Vries, E

AU - Sonke, GS

AU - Gietema, JA

PY - 2020

Y1 - 2020

U2 - 10.1001/jamaoncol.2019.6276

DO - 10.1001/jamaoncol.2019.6276

M3 - Article

SN - 2374-2437

VL - 6

SP - 528

EP - 534

JO - JAMA Oncology

JF - JAMA Oncology

IS - 4

ER -

Steenbruggen TG, Steggink LC, Seynaeve C, van der Hoeven JJ, Hooning M , Jager A et al. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. JAMA Oncology. 2020;6(4):528-534. Epub 2020 Jan 30. doi: 10.1001/jamaoncol.2019.6276